Channel 1 Multidisciplinary tumour board
Date
Fri, 07.05.2021
Time
15:45 - 17:00
Room
Channel 1
Chairs
  • D. Cameron (Edinburgh, United Kingdom)
  • M. Piccart (Brussels, Belgium)
Neoadjuvant/adjuvant treatment of HER2+ Multidisciplinary tumour board

Live introduction (ID 295)

Lecture Time
15:45 - 15:50
Speakers
  • S. Not yet confirmed (, Switzerland)
Room
Channel 1
Date
Fri, 07.05.2021
Time
15:45 - 17:00
Neoadjuvant/adjuvant treatment of HER2+ Multidisciplinary tumour board

Evaluation of HER2 status: What else needs to be known (ID 296)

Lecture Time
15:50 - 16:05
Speakers
  • A. Vincent-Salomon (Paris, France)
Room
Channel 1
Date
Fri, 07.05.2021
Time
15:45 - 17:00
Neoadjuvant/adjuvant treatment of HER2+ Multidisciplinary tumour board

Can we cure oligometastatic HER2+ disease? (ID 297)

Lecture Time
16:05 - 16:20
Speakers
  • D. Cameron (Edinburgh, United Kingdom)
Room
Channel 1
Date
Fri, 07.05.2021
Time
15:45 - 17:00
Neoadjuvant/adjuvant treatment of HER2+ Multidisciplinary tumour board

Should we maximise HER2 blockade for triple positive disease? (ID 298)

Lecture Time
16:20 - 16:35
Speakers
  • M. Piccart (Brussels, Belgium)
Room
Channel 1
Date
Fri, 07.05.2021
Time
15:45 - 17:00
Neoadjuvant/adjuvant treatment of HER2+ Multidisciplinary tumour board

Surgery in the time of pathological complete responses: How to adapt to better systemic therapy? (ID 299)

Lecture Time
16:35 - 16:50
Speakers
  • H. Lee (Seoul, Korea, Republic of)
Room
Channel 1
Date
Fri, 07.05.2021
Time
15:45 - 17:00
Neoadjuvant/adjuvant treatment of HER2+ Multidisciplinary tumour board

Q&A and live discussion (ID 300)

Lecture Time
16:50 - 17:00
Speakers
  • A. Speakers (, Switzerland)
Room
Channel 1
Date
Fri, 07.05.2021
Time
15:45 - 17:00